Announcements Trials
Browse Landscape

Phase

Phase 2 58Phase 3 30Phase 1 15Phase 1/2 13Phase NA 3Phase 2/3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 33NIH 3NETWORK 2UNKNOWN 1OTHER_GOV 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Inflammatory Breast Neoplasms 1Breast Neoplasms, Male 1

Interventions

Radiotherapy 17Magnetic Resonance Spectroscopy 16Psychiatric Rehabilitation 13Cyclophosphamide 13Early Intervention, Educational 11Methotrexate 9Doxorubicin 9Counseling 9Biopsy 9Vincristine 8Cytarabine 7Carboplatin 7Specimen Handling 6Neoadjuvant Therapy 6Immunohistochemistry 6Gene Expression Profiling 6Dexamethasone 6Chemotherapy, Adjuvant 6Prednisolone 5Peripheral Blood Stem Cell Transplantation 5Leucovorin 5Immunoenzyme Techniques 5High-Energy Shock Waves 5Fluorouracil 5Filgrastim 5Colposcopy 5Cisplatin 5Busulfan 5X-Rays 4Polymerase Chain Reaction 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × NIH × Docetaxel × Clear all
NCT00079170 2013-06-20

Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00309920 2009-02-09

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
1,234 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡